The groundbreaking treatment of this peptide represents a significant breakthrough in the care of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide825719.mybjjblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-54264878